News - Neurological, Inflammatory diseases

Filter

Popular Filters

MedImmune joins research collaboration with the University of California

MedImmune joins research collaboration with the University of California

17-02-2014

MedImmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca,…

Antibiotics and Infectious diseasesCardio-vascularInflammatory diseasesMedImmuneMetabolicsNeurologicalOncologyPharmaceuticalResearchRespiratory and PulmonaryUSA

NovaSAID partners with Cadila to develop inflammation and pain therapies

10-01-2014

Swedish research based company NovaSAID (a Karolinska Development portfolio firm) and Cadila Pharmaceuticals,…

Cadila PharmaceuticalsInflammatory diseasesNeurologicalNovaSAIDPharmaceuticalResearch

EMA reviews hypothesis on Pandemrix hypothesis; finalizes on NSAIDs and CV events

21-10-2012

The European Medicines Agency's Committee on Human Medicinal Products (CHMP) said Friday that it has…

Anti-Arthritics/RheumaticsdiclofenacGlaxoSmithKlineibuprofenInflammatory diseasesNaproxenNeurologicalPandemrixPharmaceuticalRegulationVaccines

Takeda acquires vaccine maker LigoCyte; signs multi-drug discovery deal with Advinus

05-10-2012

Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) says it is to acquire privately-held US vaccine…

Advinus TherapeuticsInflammatory diseasesLicensingLigoCyteMergers & AcquisitionsMetabolicsNeurologicalPharmaceuticalTakeda PharmaceuticalsVaccines

Merck buys in Exelixis’ PI3K-Delta program; returns product to Acumen

22-12-2011

California-based Exelixis (Nasdaq: EXEL) says it has granted US drug giant Merck & Co (NYSE: MRK) an…

Acumen PharmaceuticalsExelixisInflammatory diseasesLicensingMerck & CoNeurologicalOncologyPharmaceutical

Back to top